Victory Capital Management Inc. Increases Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Victory Capital Management Inc. grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 24.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 43,061 shares of the medical instruments supplier’s stock after purchasing an additional 8,552 shares during the period. Victory Capital Management Inc.’s holdings in DENTSPLY SIRONA were worth $1,073,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Norges Bank acquired a new stake in DENTSPLY SIRONA during the fourth quarter valued at $114,207,000. Generation Investment Management LLP grew its position in shares of DENTSPLY SIRONA by 43.4% during the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock valued at $234,830,000 after acquiring an additional 1,998,012 shares during the period. Wellington Management Group LLP increased its stake in shares of DENTSPLY SIRONA by 21.1% in the 4th quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock valued at $289,640,000 after purchasing an additional 1,419,503 shares in the last quarter. SG Americas Securities LLC raised its holdings in DENTSPLY SIRONA by 2,959.1% in the 1st quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock worth $45,584,000 after purchasing an additional 1,328,525 shares during the period. Finally, Cooke & Bieler LP boosted its position in DENTSPLY SIRONA by 16.2% during the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after purchasing an additional 1,046,105 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Trading Down 2.3 %

XRAY opened at $26.29 on Friday. The firm has a market capitalization of $5.33 billion, a price-to-earnings ratio of -59.75, a price-to-earnings-growth ratio of 1.25 and a beta of 1.00. The company’s 50 day simple moving average is $25.56 and its two-hundred day simple moving average is $27.90. DENTSPLY SIRONA Inc. has a 1-year low of $23.58 and a 1-year high of $37.60. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The company had revenue of $984.00 million for the quarter, compared to analysts’ expectations of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.51 EPS. Analysts expect that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.43%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio is currently -145.45%.

Wall Street Analysts Forecast Growth

XRAY has been the subject of a number of recent analyst reports. Robert W. Baird cut their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. Stifel Nicolaus reduced their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research report on Thursday, July 18th. Needham & Company LLC reaffirmed a “buy” rating and set a $34.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Barrington Research reissued an “outperform” rating and set a $36.00 target price on shares of DENTSPLY SIRONA in a research note on Friday. Finally, Evercore ISI decreased their price target on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $33.22.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.